Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DB | FDX |
|---|---|---|
| Price | $35.57 | $281.65 |
| Change today | ▼ 0.85% | ▼ 3.38% |
| Market cap | $66.83B | $66.66B |
| Return, 3 months | +4.6% | -11.1% |
| Return, year to date | -4.4% | +22.0% |
| Return, 1 year | +2.5% | +51.6% |
| P/E (TTM) | 10.4 | 15.2 |
| P/B | 0.9 | 2.1 |
| P/E percentile vs own 5y | 81st | 71st |
| Dividend yield | 3.21% | 2.06% |
| Revenue growth (YoY, latest qtr) | +8.4% | +12.5% |
| Net profit growth (YoY) | +9.9% | -3.1% |
| Gross margin | – | 21.8% |
| Operating margin | – | 7.0% |
| Net margin | 19.7% | 4.7% |
| Return on equity | 8.3% | 14.8% |
| Analyst target vs. price | +23.6% | +28.0% |
| Analyst buy share | 78% | 89% |
| RSI (14) | 34 | 31 |
| 30-day volatility | 25.1% | 24.5% |
| Max drawdown, 1 year | -29.7% | -13.6% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.